NYSE:EWMedical Equipment
Should Philips’ New AI Imaging Clearance for PASCAL Ace Reshape Edwards Lifesciences’ (EW) Structural Heart Narrative?
In recent days, analysts have been preparing for Edwards Lifesciences’ upcoming fiscal first-quarter 2026 earnings release, while Royal Philips secured FDA 510(k) clearance for its EchoNavigator R5.0 with DeviceGuide, an AI-guided imaging tool co-developed to support Edwards’ PASCAL Ace mitral valve repair device.
This pairing of anticipated earnings progress and fresh FDA-cleared AI imaging support underscores Edwards’ expanding presence in transcatheter structural heart therapies and...